Barry P. Rosen joined the newly founded Herbert Wertheim College of Medicine in 2009 as associate dean for basic science research. He retired as a distinguished university professor in 2025 after five decades studying heavy metal transport and detoxification.
Rosen is an international expert on arsenic whose research was continuously funded by the National Institutes of Health and the National Science Foundation for over 50 years, ranking among the top 100 longest continuously funded NIH projects.
Over his career, Rosen produced nearly 400 research publications with over 34,000 citations, earning him recognition as a Highly Ranked Scholar by Scholars GPS, placing him among the 0.05% of all scholars globally. His research was featured on the covers of five scientific journals.
Rosen is a Senior Member of the National Academy of Inventors with six patents to his name. He was elected President of the Association of Medical and Graduate Departments of Biochemistry and Fellow of the American Academy for Microbiology and the American Association for the Advancement of Science. Among his many accomplishments, Rosen notes that he trained 22 doctoral students, 55 postdoctoral associates and multiple visiting scholars.
Before joining FIU, he served as a distinguished university professor and chair of the Department of Biochemistry and Molecular Biology at Wayne State University School of Medicine, and as a professor in the Department of Biological Chemistry at the University of Maryland.
See research publications, patents and more on FIU Discovery.
- Fellow, American Association for the Advancement of Science
- American Society of Biological Chemists
- American Academy of Microbiology
- American Society for Microbiology
- American Association for the Advancement of Science
- Karmanos Comprehensive Cancer Center
- Senior Member, National Academy of Inventors
- Wayne State University Academy of Scholars
- National Academy of Inventors
- Dean’s Research Task Force, FIU Medicine
- Dr. Herbert and Nicole Wertheim Leadership in Healthcare and Medicine Lecture Series Committee
- Health and Environmental Perspectives of Metals and Drugs: a Festschrift Symposium Honoring the Career of Barry Philip Rosen, 2024
- Maximizing Investigators' Research Award, National Institute of Health (NIH), 2020
- Newly identified arsenic hypermethylating bacterium named Arsenicibacter rosenii in honor of Barry P. Rosen
- U.S. patent 7,524,229. Transgenic Saccharomyces cerivisiae and method for bioremediation.
- U.S. patent 20,150,315,647-A1. Microbiome gene expression as a biomarker of arsenic exposure
- U.S. patent 9,976,169. Biosensors for organic and inorganic arsenic
- U.S. patent 10,640,802. AfArsR gene and prokaryotic host cell
- U.S. patent 202,20,202,763-A1. Arsinothricin and methods of treating infections using arsinothricin.
- U.S. patent 11,396,520-B2. Synthesis of the organoarsenical antibiotic arsinothricin and derivatives thereof.
- U.S. patent 11,418,775-B1. Chemical Synthesis of the organoarsenical antibiotic arsinothricin.
- U.S. patent 11,877,996-B1. Arsinothricin as a multi-stage antimalarial.
- Mechanisms of transport and detoxification of transition metals, heavy metals and metalloids in bacteria, yeast, protozoans, mammals and plants
- Pathways of arsenic uptake, efflux, biotransformation and regulation in organisms from E. coli to humans
- Elucidating the enzymes and transporters of the arsenic biomethylation and organoarsenical redox cycles
Education
- Public Health Service NIH Fellow, Cornell University 1971
- Ph.D., Biochemistry, University of Connecticut 1969
- MS, Biochemistry, University of Connecticut 1968
- BS, Biology, Trinity College, Hartford, CT 1965